BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22699302)

  • 1. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.
    Garcia JM; Friend J; Allen S
    Support Care Cancer; 2013 Jan; 21(1):129-37. PubMed ID: 22699302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
    Garcia JM; Polvino WJ
    Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model.
    Northrup R; Kuroda K; Duus EM; Barnes SR; Cheatham L; Wiley T; Pietra C
    Support Care Cancer; 2013 Sep; 21(9):2409-15. PubMed ID: 23579947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol.
    Hoon SN; Fyfe K; Peddle-McIntyre CJ; Bowyer S; Hawkins F; Jeffery E; Chih HJ; Creaney J; Nowak A; Brims F
    BMJ Open Respir Res; 2020 Mar; 7(1):. PubMed ID: 32213537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
    Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
    Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis.
    Bai Y; Hu Y; Zhao Y; Yu X; Xu J; Hua Z; Zhao Z
    Support Care Cancer; 2017 May; 25(5):1651-1659. PubMed ID: 28074289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
    Katakami N; Uchino J; Yokoyama T; Naito T; Kondo M; Yamada K; Kitajima H; Yoshimori K; Sato K; Saito H; Aoe K; Tsuji T; Takiguchi Y; Takayama K; Komura N; Takiguchi T; Eguchi K
    Cancer; 2018 Feb; 124(3):606-616. PubMed ID: 29205286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appetite and food intake results from phase I studies of anamorelin.
    Blum RA; Mair S; Duus EM
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1027-1035. PubMed ID: 31074178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
    Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K
    Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
    Temel JS; Abernethy AP; Currow DC; Friend J; Duus EM; Yan Y; Fearon KC
    Lancet Oncol; 2016 Apr; 17(4):519-531. PubMed ID: 26906526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study.
    Strasser F; Lutz TA; Maeder MT; Thuerlimann B; Bueche D; Tschöp M; Kaufmann K; Holst B; Brändle M; von Moos R; Demmer R; Cerny T
    Br J Cancer; 2008 Jan; 98(2):300-8. PubMed ID: 18182992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of anamorelin (ONO-7643) on cachexia in cancer patients: Systematic review and meta-analysis of randomized controlled trials.
    Rezaei S; de Oliveira LC; Ghanavati M; Shadnoush M; Akbari ME; Akbari A; Hadizadeh M; Ardehali SH; Wakabayashi H; Elhelali A; Rahmani J
    J Oncol Pharm Pract; 2023 Oct; 29(7):1725-1735. PubMed ID: 37525932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.
    Currow DC; Maddocks M; Cella D; Muscaritoli M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anamorelin for cancer cachexia.
    Nishie K; Sato S; Hanaoka M
    Drugs Today (Barc); 2022 Mar; 58(3):97-104. PubMed ID: 35274629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of pharmacological cachexia interventions: systematic review and network meta-analysis.
    Saeteaw M; Sanguanboonyaphong P; Yoodee J; Craft K; Sawangjit R; Ngamphaiboon N; Shantavasinkul PC; Subongkot S; Chaiyakunapruk N
    BMJ Support Palliat Care; 2021 Mar; 11(1):75-85. PubMed ID: 33246937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
    Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
    Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ
    Nakanishi Y; Higuchi J; Honda N; Komura N
    Nihon Yakurigaku Zasshi; 2021; 156(6):370-381. PubMed ID: 34719572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
    Zhang H; Garcia JM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.